MSFT 414.2 2.0901% AAPL 220.11 -0.3621% NVDA 108.1 1.5309% GOOGL 148.66 -0.0336% GOOG 150.01 0.3143% AMZN 179.55 2.366% META 504.79 0.0% AVGO 148.21 5.2478% TSLA 226.17 4.5776% TSM 162.43 -0.215% LLY 901.25 -0.7729% V 285.34 -0.0945% JPM 205.56 -5.1889% UNH 599.03 0.8298% NVO 129.78 -1.6147% WMT 78.81 1.9007% LVMUY 135.45 -0.7401% XOM 110.82 -3.6432% LVMHF 676.0 -1.0402% MA 488.02 0.1909%
Last update at 2024-09-11T00:01:00Z
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | -168.40000M | -258.60000M | -147.90000M | -43.10000M | -50.30000M |
Minority interest | 3.30M | - | 149.00M | 43.60M | 51.00M |
Net income | -171.80000M | -260.10000M | -149.00000M | -43.60000M | -55.10000M |
Selling general administrative | 141.00M | 151.10M | 202.10M | 259.60M | 259.70M |
Selling and marketing expenses | 53.90M | 52.80M | 47.80M | 53.10M | 58.20M |
Gross profit | 350.80M | 142.90M | 210.10M | 451.70M | 436.70M |
Reconciled depreciation | 98.30M | 107.70M | 105.10M | 110.10M | 118.10M |
Ebit | 133.40M | -81.90000M | -68.60000M | 129.20M | 125.20M |
Ebitda | 229.60M | 25.80M | 36.50M | 239.30M | 243.30M |
Depreciation and amortization | 96.20M | 107.70M | 105.10M | 110.10M | 118.10M |
Non operating income net other | -125.90000M | -23.50000M | 49.90M | 15.20M | -17.70000M |
Operating income | 133.40M | -81.90000M | -68.60000M | 129.20M | 122.90M |
Other operating expenses | 4552.60M | 3229.70M | 2334.30M | 3330.60M | 3379.40M |
Interest expense | 175.90M | 149.50M | 125.90M | 134.60M | 155.50M |
Tax provision | 3.40M | 1.50M | 1.10M | 0.50M | 0.70M |
Interest income | - | - | - | 125.60M | 121.70M |
Net interest income | -175.90000M | -149.50000M | -125.90000M | -134.60000M | -155.50000M |
Extraordinary items | - | - | - | - | -4.10000M |
Non recurring | 0.70M | 4.10M | 6.80M | 37.00M | - |
Other items | - | - | - | - | - |
Income tax expense | 3.40M | 1.50M | 1.10M | 0.50M | 0.70M |
Total revenue | 4686.70M | 3148.00M | 2268.20M | 3452.60M | 3497.50M |
Total operating expenses | 216.70M | 224.60M | 276.20M | 329.70M | 318.60M |
Cost of revenue | 4335.90M | 3005.10M | 2058.10M | 3000.90M | 3060.80M |
Total other income expense net | -301.80000M | -176.70000M | -79.30000M | -172.30000M | -12.90000M |
Discontinued operations | - | - | - | - | -4.10000M |
Net income from continuing ops | -171.80000M | -260.10000M | -146.80000M | -42.60000M | -49.60000M |
Net income applicable to common shares | -165.10000M | -254.90000M | -292.80000M | -85.30000M | -104.70000M |
Preferred stock and other adjustments | - | -5.20000M | -3.00000M | -0.90000M | - |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Total assets | 2751.30M | 2741.80M | 2127.90M | 1808.30M | 1857.80M |
Intangible assets | 28.50M | 36.30M | 45.80M | 57.60M | 71.20M |
Earning assets | - | - | - | - | - |
Other current assets | 54.40M | 19.20M | 14.90M | 10.20M | 11.00M |
Total liab | 2996.00M | 3029.50M | 2513.00M | 1936.90M | 1836.20M |
Total stockholder equity | -491.60000M | -287.70000M | -10.10000M | -12.30000M | -10.60000M |
Deferred long term liab | - | 119.70M | 82.30M | 34.20M | 31.70M |
Other current liab | 455.50M | 819.00M | 193.20M | 252.10M | 192.90M |
Common stock | - | -529.90000M | -378.80000M | -125.30000M | 20.20M |
Capital stock | - | - | - | - | - |
Retained earnings | - | -421.90000M | -260.10000M | - | - |
Other liab | - | 100.60M | 101.30M | 28.20M | 28.70M |
Good will | 173.00M | 173.00M | 173.00M | 173.00M | 171.40M |
Other assets | - | 122.60M | 169.10M | 37.20M | 36.50M |
Cash | 14.70M | 35.20M | 38.10M | 109.40M | 19.10M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 1112.70M | 1352.10M | 899.80M | 544.50M | 565.00M |
Current deferred revenue | 13.50M | - | 333.10M | 68.80M | 79.50M |
Net debt | 2175.70M | 1632.30M | 1546.30M | 1299.10M | 1285.80M |
Short term debt | 321.70M | 90.70M | 72.50M | 44.30M | 62.40M |
Short long term debt | 55.70M | 19.10M | 7.40M | 2.30M | 1.50M |
Short long term debt total | 2190.40M | 1667.50M | 1584.40M | 1408.50M | 1304.90M |
Other stockholder equity | -237.50000M | 142.50M | 10.10M | 12.30M | 10.60M |
Property plant equipment | - | 1482.00M | 1107.40M | 919.80M | 973.50M |
Total current assets | 794.70M | 820.40M | 632.60M | 534.90M | 512.10M |
Long term investments | - | - | - | - | 0.00000M |
Net tangible assets | - | -497.00000M | -607.70000M | -359.20000M | -221.00000M |
Short term investments | - | - | - | - | - |
Net receivables | 286.20M | 268.00M | 253.00M | 160.40M | 188.50M |
Long term debt | 1829.70M | 1537.20M | 1418.80M | 1316.30M | 1207.10M |
Inventory | 439.40M | 498.00M | 326.60M | 254.90M | 292.60M |
Accounts payable | 322.00M | 442.40M | 301.00M | 179.30M | 230.20M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -7.20000M | -8.30000M | -10.10000M | -12.30000M | -10.60000M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | - |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 134.40M | 122.60M | 169.10M | 37.20M | 36.50M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 1956.60M | 1921.40M | 1495.30M | 1273.40M | 1345.70M |
Capital lease obligations | 114.60M | 111.20M | 158.20M | 89.90M | 96.30M |
Long term debt total | - | 1539.70M | 1418.80M | 1319.40M | 1209.50M |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Investments | -400.20000M | -536.00000M | -82.80000M | -46.30000M | 5.00M |
Change to liabilities | - | 83.70M | 71.00M | 38.00M | 95.50M |
Total cashflows from investing activities | - | -536.00000M | -82.80000M | -46.30000M | 14.50M |
Net borrowings | - | -286.70000M | 88.90M | 105.70M | -360.40000M |
Total cash from financing activities | 266.20M | 348.70M | 139.30M | 73.80M | -343.00000M |
Change to operating activities | - | -41.40000M | 90.80M | 53.30M | 10.50M |
Net income | 47.10M | -171.80000M | -260.10000M | -149.00000M | -43.60000M |
Change in cash | -20.50000M | -86.70000M | 12.50M | 90.30M | -136.60000M |
Begin period cash flow | 35.20M | 121.90M | 109.40M | 19.10M | 155.70M |
End period cash flow | 14.70M | 35.20M | 121.90M | 109.40M | 19.10M |
Total cash from operating activities | -14.90000M | 100.60M | -44.00000M | 62.80M | 191.90M |
Issuance of capital stock | - | - | - | - | - |
Depreciation | 182.90M | 98.30M | 107.70M | 105.10M | 110.10M |
Other cashflows from investing activities | - | 0.20M | 0.10M | 1.00M | 64.40M |
Dividends paid | - | - | - | - | - |
Change to inventory | 25.10M | -190.80000M | -27.00000M | 14.00M | 16.30M |
Change to account receivables | -19.20000M | -15.00000M | -91.40000M | 25.50M | -37.00000M |
Sale purchase of stock | 0.00000M | -4.40000M | 0.00000M | 0.00000M | 0.10M |
Other cashflows from financing activities | 460.50M | 2655.50M | 1520.00M | 1097.00M | 1064.90M |
Change to netincome | - | 125.40M | 42.80M | 31.50M | 38.90M |
Capital expenditures | 271.80M | 536.20M | 82.90M | 44.00M | 54.90M |
Change receivables | - | -15.00000M | -91.40000M | 25.50M | -37.00000M |
Cash flows other operating | - | 153.20M | -47.70000M | 94.00M | -13.70000M |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | -86.70000M | 12.50M | 90.30M | -136.60000M |
Change in working capital | -73.00000M | -127.30000M | 104.40M | 78.10M | 78.90M |
Stock based compensation | 14.70M | 17.30M | 50.70M | 5.50M | 5.90M |
Other non cash items | -185.00000M | 285.60M | -75.70000M | 20.10M | -28.40000M |
Free cash flow | -286.70000M | -435.60000M | -126.90000M | 18.80M | 137.00M |
Sector: Energy Industry: Oil & Gas E&P
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
CLMT Calumet Specialty Products Partners |
-0.03 0.19% | 15.98 | - | 11.35 | 0.29 | 19.32 | 0.77 | 7.71 |
COP ConocoPhillips |
-1.6 1.52% | 104.00 | 12.82 | 11.12 | 2.24 | 2.90 | 2.47 | 5.63 |
CNQ Canadian Natural Resources Ltd |
-1.28 3.82% | 32.21 | 15.51 | 14.24 | 2.37 | 2.92 | 2.26 | 5.34 |
EOG EOG Resources Inc |
-1.53 1.27% | 118.97 | 9.09 | 8.98 | 3.01 | 2.57 | 2.97 | 5.16 |
PEXNY PTT Exploration & Production |
1.66 11.13% | 16.58 | 25.79 | 24.51 | 5.92 | 3.66 | 0.05 | 0.08 |
Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Performance brands; Montana/Renewables; and Corporate segments. The Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. Its Montana/Renewables segment focuses on processing renewable feedstocks into renewable diesel, sustainable aviation fuel, renewable hydrogen, renewable natural gas, renewable propane, and renewable naphtha. It also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. The Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. The company serves wholesale distributors and retail chains. Calumet GP, LLC serves as the general partner for Calumet Specialty Products Partners, L.P. The company was founded in 1919 and is headquartered in Indianapolis, Indiana.
2780 Waterfront Parkway East Drive, Indianapolis, IN, United States, 46214
Name | Title | Year Born |
---|---|---|
Mr. Stephen P. Mawer | Exec. Chairman of Calumet GP, LLC | 1965 |
Mr. Louis Todd Borgmann | CEO of Calumet GP, LLC | 1983 |
Mr. Bruce A. Fleming | Exec. VP of Montana Renewables & Corp. Devel. of Calumet GP, LLC | 1957 |
Mr. Scott Obermeier | Exec. VP of Specialty Products & Solutions of Calumet GP, LLC | 1973 |
Mr. Vincent Donargo | Exec. VP & CFO | 1961 |
Mr. Ryan A. Willman | Chief Accounting Officer & Principal Accounting Officer of Calumet GP, LLC | 1978 |
Brad McMurray | Director of Investor Relations | NA |
Mr. Marc Lawn | Exec. VP of Performance Brands of Calumet GP, LLC | 1973 |
Mr. Chris Hodges | Alpha IR | NA |
Mr. Louis Todd Borgmann | Chief Executive Officer of Calumet GP, LLC | 1983 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.